Age-related increase in xanthine oxidase activity in human plasma and rat tissues

References

• Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956; 11: 298–300
   PubMedGoogle Scholar
• Barja G. Rate of generation of oxidative stress-related damage and animal longevity. Free Radic Biol Med 2002; 33: 1167–1172
   PubMed Web of Science ®Google Scholar
• Newaz MA, Yousefipour Z, Oyekan A. Oxidative stress-associated vascular aging is xanthine oxidase-dependent but not NAD(P)H oxidase-dependent. J Cardiovasc Pharmacol 2006; 48: 88–94
   PubMedGoogle Scholar
• Landmesser U, Spiekermann S, Dikalov S, Tatge H, Wilke R, Kohler C, Harrison DG, Hornig B, Drexler H. Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase. Circulation 2002; 106: 3073–3078
   PubMed Web of Science ®Google Scholar
• Viña J, Gimeno A, Sastre J, Desco C, Asensi M, Pallardó FV, Cuesta A, Ferrero JA, Terada LS, Repine JE. Mechanism of free radical production in exhaustive exercise in humans and rats; role of xanthine oxidase and protection by allopurinol IUBMB. Life 2000; 49: 539–544
   PubMedGoogle Scholar
• Desco MC, Asensi M, Marquez R, Martinez-Valls J, Vento M, Pallardo FV, Sastre J, Vina J. Xanthine oxidase is involved in free radical production in type 1 diabetes: protection by allopurinol. Diabetes 2002; 51: 1118–1124
   PubMed Web of Science ®Google Scholar
• Butler R, Morris AD, Belch JJ, Hill A, Struthers AD. Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension 2000; 35: 746–751
   PubMed Web of Science ®Google Scholar
• White CR, Darley-Usmar V, Berrington WR, McAdams M, Gore JZ, Thompson JA, Parks DA, Tarpey MM, Freeman BA. Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits. Proc Natl Acad Sci USA 1996; 93: 8745–8749
   PubMed Web of Science ®Google Scholar
• Netea MG, Kullberg BJ, Blok WL, Netea RT, van der Meer JW. The role of hyperuricemia in the increased cytokine production after lipopolysaccharide challenge in neutropenic mice. Blood 1997; 89: 577–582
   PubMed Web of Science ®Google Scholar
• Zou Y, Jung KJ, Kim JW, Yu BP, Chung HY. Alteration of soluble adhesion molecules during aging and their modulation by calorie restriction. FASEB J 2004;18:320–322. Epub 19 December 2003.
   PubMed Web of Science ®Google Scholar
• Csiszar A, Ungvari Z, Edwards JG, Kaminski P, Wolin MS, Koller A, Kaley G. Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function. Circ Res 2002; 90: 1159–1166
   PubMed Web of Science ®Google Scholar
• Farquharson CA, Butler R, Hill A, Belch JJ, Struthers AD. Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation 2002; 106: 221–226
   PubMed Web of Science ®Google Scholar
• Doehner W, Schoene N, Rauchhaus M, Leyva-Leon F, Pavitt DV, Reaveley DA, Schuler G, Coats AJ, Anker SD, Hambrecht R. Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies. Circulation 2002; 105: 2619–2624
   PubMed Web of Science ®Google Scholar
• O'Driscoll JG, Green DJ, Rankin JM, Taylor RR. Nitric oxide-dependent endothelial function is unaffected by allopurinol in hypercholesterolaemic subjects. Clin Exp Pharmacol Physiol 1999; 26: 779–783
   PubMedGoogle Scholar
• Eskurza I, Kahn ZD, Seals DR. Xanthine oxidase does not contribute to impaired peripheral conduit artery endothelium-dependent dilatation with ageing. J Physiol 2006; 571: 661–668
   PubMedGoogle Scholar
• Beckman JS, Parks DA, Pearson JD, Marshall PA, Freeman BA. A sensitive fluorimetry assay for measuring xanthine dehydrogenase and oxidase in tissues. Free Radical Biol Med 1989; 6: 607–615
   PubMed Web of Science ®Google Scholar
• White CR, Darley-Usmar V, Berrington WR, McAdams M, Gore JZ, Thompson JA, Parks DA, Tarpey MM, Freeman BA. Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits. Proc Natl Acad Sci USA 1996; 93: 8745–8749
   PubMed Web of Science ®Google Scholar
• Lüscher T, Noll G. The endothelium in coronary vascular control. Heart Dis 1995; 3: 1–10
   Google Scholar
• Tschudi M, Barton M, Bersinger N, Moreau P, Cosentino F, Noll G, Malinski T, Lüscher T. Effect of age on kinetics of nitric oxide release in rat aorta and pulmonary artery. J Clin Inves 1996; 98: 899–905
   PubMed Web of Science ®Google Scholar
• van der Loo B, Labugger R, Skepper JN, Bachschmid M, Kilo J, Powell JM, Palacios-Callender M, Erusalimsky JD, Quaschning T, Malinski T, Gygi D, Ullrich V, Lüscher TF. Enhanced peroxynitrite formation is associated with vascular aging. J Exp Med 2000; 192: 1731–1744
   PubMed Web of Science ®Google Scholar
• Adachi T, Weisbrod RM, Pimentel DR, Ying J, Sharov VS, Schoneich C, Cohen RA. S-Glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide. Nat Med 2004; 10: 1200–1207
   PubMed Web of Science ®Google Scholar
• Cai H, Harrison D. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 2000; 87: 840–844
   PubMed Web of Science ®Google Scholar
• Hassoun PM, Yu FS, Shedd AL, Zulueta JJ, Thannickal VJ, Lanzillo JJ, Fanburg BL. Regulation of endothelial cell xanthine dehydrogenase/xanthine oxidase gene expression by oxygen tension. Am J Physiol 1994; 266: L163–L171
   Google Scholar
• Kayyali US, Donaldson C, Huang H, Abdelnour R, Hassoun PM. Phosphorylation of xanthine dehydrogenase/oxidase in hypoxia. J Biol Chem 2001; 276: 14359–14365
   PubMed Web of Science ®Google Scholar
• Poss WB, Hueckstaeadt TP, Panus PC, Freeman BA, Hoidal JR. Regulation of xanthine dehydrogenase and xanthine oxidase activity by hypoxia. Am J Physiol 1996; 270: L941–L946
   Google Scholar
• Terada LS, Piermattei D, Shibao GN, McManaman JL, Wright RM. Hypoxia regulates xanthine dehydrogenase activity at pre and posttranslational levels. Arch Biochem Biophys 1997; 348: 163–168
   PubMed Web of Science ®Google Scholar
• Hassoun PM, Yu FS, Cote CG, Zulueta JJ, Sawhney R, Skinner KA, Skinner HB, Parks DA, Lanzillo JJ. Upregulation of xanthine oxidase by lipopolysaccharide, interleukin-1, and hypoxia. Role in acute lung injury. Am J Respir Crit Care Med 1998; 158: 299–305
   PubMed Web of Science ®Google Scholar
• Jarasch ED, Grund C, Bruder G, Heid HW, Keenan TW, Franke WW. Localization of xanthine oxidase in mammary-gland epithelium and capillary endothelium. Cell 1981; 25: 67–82
   PubMed Web of Science ®Google Scholar
• Kooij A, Schijns M, Frederiks WM, Van NCJ, James J. Distribution of xanthine oxidoreductase activity in human tissues: a histochemical and biochemical study. Virchows Arch B Cell Pathol 1992; 63: 17–23
   Google Scholar
• Rouquette M, Page S, Bryant R, Benboubetra M, Stevens CR, Blake DR, Whish WD, Harrison R, Tosh D. Xanthine oxidoreductase is asymmetrically localised on the outer surface of human endothelial and epithelial cells in culture. FEBS Lett 1998; 426: 397–401
   PubMed Web of Science ®Google Scholar
• Granger DN. Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury. Am J Physiol 1994; 266: H1269–H1275
   Google Scholar
• Grace PA. Ischaemia-reperfusion injury. Br J Surg 1994; 81: 637–647
   PubMed Web of Science ®Google Scholar
• Ukai T, Cheng C, Tachibana H, Igawa A, Zhang Z, Cheng H, Little W. Allopurinol enhances the contractile response to dobutamine and exercise in dogs with pacing-induced heart failure. Circulation 2001; 103: 750–755
   PubMed Web of Science ®Google Scholar
• Kogler H, Fraser H, McCune S, Altschuld R, Marban E. Disproportionate enhancement of myocardial contractility by the xanthine oxidase inhibitor oxypurinol in failing rat myocardium. Cardiovasc Res 2003; 59: 582–592
   PubMed Web of Science ®Google Scholar
• Ekelund UE, Harrison RW, Shokek O, Thakkar RN, Tunin RS, Senzaki H, Kass DA, Marban E, Hare JM. Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing-induced heart failure. Circ Res 1999; 85: 437–445
   PubMed Web of Science ®Google Scholar
• Cappola T, Kass D, Nelson G, Berger R, Rosas G, Kobeissi Z, Marban E, Hare J. Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy. Circulation 2001; 104: 2407–2411
   PubMed Web of Science ®Google Scholar
• Schwartz CJ, Valente AJ, Sprague EA. A modern view of atherosclerosis. Am J Cardio 1993; 71: 9B–14B
   PubMed Web of Science ®Google Scholar
• O'Hara Y, Peterson T, Harrison D. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 1993; 91: 2546–2551
   PubMedGoogle Scholar
• Kayyali U, Budhiraja R, Pennella C, Cooray S, Lanzillo J, Chalkley R, Hassoun P. Upregulation of xanthine oxidase by tobacco smoke condensate in pulmonary endothelial cells. Toxicol Appl Pharmacol 2003; 188: 59–68
   PubMedGoogle Scholar
• Guthikonda S, Sinkey C, Barenz T, Haynes W. Xanthine oxidase inhibition reverses endothelial dysfunction in heavy smokers. Circulation 2003; 107: 416–421
   PubMed Web of Science ®Google Scholar
• McNally J, Davis M, Giddens D, Saha A, Hwang J, Dikalov S, Jo H, Harrison D. Role of xanthine oxidoreductase and the NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress. Am J Physiol 2003; 285: H2290–H2297
   PubMed Web of Science ®Google Scholar
• Taddei S, Virdis A, Mattei P, Ghiadoni L, Fasolo C, Sudano I, Salvetti A. Hypertension causes premature aging of endothelial function in humans. Hypertension 1997; 29: 736–743
   PubMed Web of Science ®Google Scholar
• Patetsios P, Song M, Shutze W, Papas C, Rodino W, Ramírez J, Panetta T. Identification or uric acid and xanthine oxidase in atherosclerotic plaque. Am J Cardiol 2001; 88: 188–191
   PubMed Web of Science ®Google Scholar
• Swain J, Gutteridge JMC. Prooxidant iron and copper, with ferroxidase and xanthine oxidase activities in human atherosclerotic material. FEBS Lett 1995; 368: 513–515
   PubMed Web of Science ®Google Scholar
• Johnson R, Kang D, Feig D, Kivlighn S, Kanellis J, Watanabe S, Tuttle K, Rodríguez-Iturbe B, Herrera-Acosta J, Mazzali M. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?. Hypertension 2003; 41: 1183–1190
   PubMed Web of Science ®Google Scholar
• Fang J, Alderman M. Serum uric acid and cardiovascular mortality. The NHANES Iepidemiologic follow-up study. JAMA 2000; 283: 2404–2410
   PubMed Web of Science ®Google Scholar
• Anker S, Doehner W, Rauchhaus M, Sharma R, Francis D, Knosalla C, Davos C, Cicoira M, Shamim W, Kemp M, Segal R, Osterziel K, Leyva F, Hetzer R, Ponikowski P, Coats A. Uric acid and survival in chronic heart failure. Circulation 2003; 107: 1991–1997
   PubMed Web of Science ®Google Scholar
• Cardillo C, Kilcoyne CM, Cannon RO 3rd, Quyyumi AA, Panza JA. Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients. Hypertension 1997;30:57–63.
   PubMed Web of Science ®Google Scholar
• Guthikonda S, Woods K, Sinkey CA, Haynes WG. Role of xanthine oxidase in conduit artery endothelial dysfunction in cigarette smokers. Am J Cardiol 2004; 93: 664–668
   PubMed Web of Science ®Google Scholar